These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26925062)

  • 1. The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH.
    Pacifici R
    Front Immunol; 2016; 7():57. PubMed ID: 26925062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone.
    Pacifici R
    Ann N Y Acad Sci; 2016 Jan; 1364(1):11-24. PubMed ID: 26662934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.
    Li JY; Yu M; Tyagi AM; Vaccaro C; Hsu E; Adams J; Bellido T; Weitzmann MN; Pacifici R
    J Bone Miner Res; 2019 Feb; 34(2):349-360. PubMed ID: 30399207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
    Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
    J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
    Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
    J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoimmunology and its implications for transplantation.
    Pacifici R
    Am J Transplant; 2013 Sep; 13(9):2245-54. PubMed ID: 23915249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
    Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
    Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
    Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
    J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
    J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess.
    Kuriwaka-Kido R; Kido S; Miyatani Y; Ito Y; Kondo T; Omatsu T; Dong B; Endo I; Miyamoto K; Matsumoto T
    Endocrinology; 2013 Mar; 154(3):1156-67. PubMed ID: 23397032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.
    Onal M; St John HC; Danielson AL; Pike JW
    J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
    Rifas L; Arackal S; Weitzmann MN
    J Cell Biochem; 2003 Mar; 88(4):650-9. PubMed ID: 12577299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of T cells in the modulation of PTH action: physiological and clinical significance.
    Pacifici R
    Endocrine; 2013 Dec; 44(3):576-82. PubMed ID: 23729167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo.
    Grey A; Mitnick MA; Masiukiewicz U; Sun BH; Rudikoff S; Jilka RL; Manolagas SC; Insogna K
    Endocrinology; 1999 Oct; 140(10):4683-90. PubMed ID: 10499526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption.
    Radeff JM; Nagy Z; Stern PH
    Exp Cell Res; 2001 Aug; 268(2):179-88. PubMed ID: 11478844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.
    Shinoda Y; Kawaguchi H; Higashikawa A; Hirata M; Miura T; Saito T; Nakamura K; Chung UI; Ogata N
    J Cell Biochem; 2010 Mar; 109(4):755-63. PubMed ID: 20058231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice.
    Li JY; D'Amelio P; Robinson J; Walker LD; Vaccaro C; Luo T; Tyagi AM; Yu M; Reott M; Sassi F; Buondonno I; Adams J; Weitzmann MN; Isaia GC; Pacifici R
    Cell Metab; 2015 Nov; 22(5):799-810. PubMed ID: 26456334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.